PALM CITY, Fla., Aug. 9, 2011 (GLOBE NEWSWIRE) -- GelStat Corporation (Pink Sheets:GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain, inflammation and sleep disorders, is pleased to announce it has retained Scarsdale Equities LLC as its financial advisor to explore various strategic alternatives.
"The Company is in the final stages of its restructuring that began in 2008 and the timing is optimal for us to fully analyze all of our strategic options," commented Gerald Kieft, CEO of GelStat Corporation. "We are very pleased to have retained Scarsdale Equities as our advisory firm."
About Scarsdale Equities LLC
Scarsdale Equities LLC is an institutional broker/dealer located in New York City. The firm's services include investment banking, institutional equity brokerage, discretionary account management, and start-up consulting and advisory services for money managers. Special investment banking focus is devoted to: 1) extractive industries, including oil and gas, energy services, and mining of precious metals, base metals, and fertilizers, 2) healthcare financing, 3) specialty real estate, and 4) alternative energy. The firm is a member of the Financial Industry Regulatory Authority (FINRA) and Securities Investor Protection Corp. (SIPC). The firm's website is located at www.scarsdale-equities.com.
ABOUT GELSTAT CORPORATION
GelStat Corporation is dedicated to providing safe and effective over-the-counter (OTC) treatments for pain, inflammation and sleep disorders. GelStat's first two products GelStat Migraine and GelStat Sleep are sold through direct-to-consumer channels as well as in a limited number of independent retailers and pharmacies. The Company also has a suite of additional healthcare products in various stages of development that address large consumer markets. For more information, visit www.gelstat.com.